Skip to content
LexBuild

Medical Gas Regulation Review; Announcement of Public Meeting; Correction

---
identifier: "/us/fr/2013-28083"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Medical Gas Regulation Review; Announcement of Public Meeting; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2013-28083"
section_name: "Medical Gas Regulation Review; Announcement of Public Meeting; Correction"
positive_law: false
currency: "2013-11-25"
last_updated: "2013-11-25"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2013-28083"
document_type: "proposed_rule"
publication_date: "2013-11-25"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part null"
fr_citation: "78 FR 70248"
fr_volume: 78
docket_ids:
  - "Docket No. FDA-2013-N-0001"
effective_date: "2013-11-25"
fr_action: "Notice of public meeting; correction."
---

#  Medical Gas Regulation Review; Announcement of Public Meeting; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice of public meeting; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a document that appeared in the *Federal Register* of November 1, 2013 (78 FR 65588). The document announced a public meeting entitled “Medical Gas Regulation Review.” The document was published with an incorrect Web site. This document corrects that error.

**DATES:**

Effective November 25, 2013.

**FOR FURTHER INFORMATION CONTACT:**

Mary Gross, Office of Executive Programs, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-3519, FAX: 301-847-8753, email: *[email protected];* or Christine Kirk, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-2465, FAX: 301-847-8440, email: *[email protected]* ; or Urvi Desai, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, email: *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Friday, November 1, 2013, in FR Doc. 2013-26056, on page 65588 the following corrections are made:

1. In the third column, in the last sentence of the second paragraph under *Registration and Requests for Oral Presentations,**http://www.fda.gov/Drugs/NewEvents/ucm370351.htm”* is corrected to read “ *http://www.fda.gov/Drugs/NewsEvents/ucm370351.htm”.*

2. In the third column, in the first sentence of the third paragraph under *Registration and Requests for Oral Presentations,**http://www.fda.gov/Drugs/NewEvents/ucm370351.htm”* is corrected to read “ *http://www.fda.gov/Drugs/NewsEvents/ucm370351.htm”.*

Dated: November 19, 2013.

Leslie Kux,

Assistant Commissioner for Policy.